🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hall technique for primary teeth depends on the idea of isolation of th...
Status
Completed
Location
Dr. Rasha Farouk Sharaf
Start Date
2021-03-10
Trial ID
NCT05265104
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This study aims to evaluate the effects of virtual reality (VR) and mixed r...
Status
Completed
Location
Akdeniz University
Start Date
2025-03-10
Trial ID
NCT06889597
Treatments Being Tested
The goal of this clinical trial is to learn how different protein types aff...
Status
Recruiting
Location
UPMC Montefiore - Clinical and Translational Research Center (CTRC)
Start Date
2026-03-24
Trial ID
NCT07121010
This cluster-randomized controlled trial tests whether a short, standardize...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-15
Trial ID
NCT07781527
Treatments Being Tested
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
The present study is a randomized, placebo-controlled, parallel study. 250 ...
Status
Recruiting
Location
Shivam Hospital
Start Date
2025-02-20
Trial ID
NCT06473246
This study examines a multi-ingredient nutraceutical designed to support se...
Status
Completed
Location
Gplife Healthcare Private Limited
Start Date
2025-12-24
Trial ID
NCT07534878
Treatments Being Tested
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested